We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.
We are committed to bringing more of our medicines to more people, no matter where they are. For all our new medicines, we will systematically integrate access strategies in how we research, develop and deliver globally.
People and Culture
Novartis is building an Inspired, Curious and Unbossed culture.
When it comes to cancer, there’s power in a good partner
Combinations of drugs could hold the key to overcoming some of the biggest challenges in lung and other cancers.
To make a difference, start with patients
John Tsai, Head of Global Drug Development and Chief Medical Officer, describes how he balances innovation and patient needs.
Solving the puzzle of immunotherapy
From an eccentric idea to a revolution in medicine – the history of immunotherapy and a peek into its future.
Novartis COVID-19 Information Center
Novartis is responding to the coronavirus disease (COVID-19) outbreak. The information center provides a central hub for news, guidance and resources.
Stopping this coronavirus – and the next one
Inside the hunt for new antivirals to combat the current pandemic and to prepare for future ones.
The Novartis Commitment to Patients and Caregivers
Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives.
Environmental, Social and Governance
We have a responsibility and opportunity to lead the world in creating a positive social change, embracing societal impact as a core business objective.
Live is the in-house magazine of Novartis which is now available in a digital format. Explore stories, podcasts and more from across the company.
Integrating ESG into strategy – Novartis Lecture 2021
Not a nice-to-have asset, but rather a critical driver for business and impact: watch the recording of the 2021 Novartis Lecture by Prof. George Serafeim from Harvard Business School on how to successfully integrate ESG objectives into corporate strategy.